AIMEDBIO Funding: $67M Raised, Growth (2025)

AIMEDBIO is based in Seoul, South Korea. It has raised $67M in total funding. Latest round: Growth.

AIMEDBIO funding overview

AIMEDBIO is based in Seoul, South Korea. AIMEDBIO has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in June 2025. The round record for AIMEDBIO runs through 2025; nothing later has been disclosed. Investors on record include Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities. 5 distinct backers are named across the disclosed rounds.

AIMEDBIO at a glance

Total raised
$67M
Latest round
Growth
Latest round date
June 2025
Headquarters
Seoul, South Korea
Notable investors
Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities

Frequently asked about AIMEDBIO funding

How much has AIMEDBIO raised?
AIMEDBIO has raised $67M in total disclosed funding across the rounds on record.
Who has invested in AIMEDBIO?
Intervest, DS Asset Management, Samsung Life Insurance Foundation, SMB Investment Partners, Mirae Asset Securities are named among the investors backing AIMEDBIO.
What was the latest AIMEDBIO funding round?
The most recent disclosed round is a Growth, announced in June 2025.
Where is AIMEDBIO based?
AIMEDBIO is based in Seoul, South Korea.
When did AIMEDBIO last raise?
The last disclosed AIMEDBIO round closed in June 2025 at Growth.

We update the AIMEDBIO record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Seoul and their backers are listed below.

Companies related to AIMEDBIO (24)

Browse related funding lists (6)

Company funding database · Investor directory · Founder database · Mega-rounds 2026